UNSPSC 51102904: Pyrimethamine/sulfadoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP101. This VA Drug Class (AP101) classifies this compound as belonging to the group ANTIMALARIALS.

UNSPSC 51102904 Pyrimethamine/sulfadoxine (Commodity) codes the procurement of antimalarial pharmaceutical products, though recent state and local solicitation activity under this code does not reflect purchases of pyrimethamine/sulfadoxine specifically. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract on August 28, 2026, through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — antibiotics unrelated to the code's nominal antimalarial scope. Seminole County, Florida posted an IFB on June 30, 2026, for Naloxone and Safe Drug Deactivation Systems, a opioid-overdose intervention product that also falls outside the pyrimethamine/sulfadoxine category. The mismatch between the code designation and the products actually being procured suggests either miscoding at the issuing body or limited current state and local demand for pyrimethamine/sulfadoxine itself.

Activity is confined to two jurisdictions: the Illinois Department of Public Health and Seminole County, Florida. The Illinois award (Solicitation 26482DPHPREPDB53392) was a $2,999,999.11 IFB over three years with 12-month initial term and two renewal options; the Seminole County IFB (IFB60459723LAS) sought annual delivery of 1,900 units of Naloxone and 800 drug deactivation systems over an initial two-year term with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. No recent open solicitations under this code for pyrimethamine/sulfadoxine are present in the source.